Inter Med Oncology is categorized under Oncologists in Homewood, IL and active since 1978.
Inter Med Oncology was established in 1978, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jan Schneider, Office Manager at the company’s single location by writing to 17901 Governors Highway, Homewood, Illinois IL 60430 or by phoning (708) 957-2100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Inter Med Oncology |
| Contact Person: | Jan Schneider, Office Manager |
| Address: | 17901 Governors Highway, Homewood, Illinois 60430 |
| Phone Number: | (708) 957-2100 |
| Website Address: | alphamedphysicians.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1978 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Inter Med Oncology was started in 1978 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jan Schneider, Office Manager for inquiries that concern Inter Med Oncology by calling the company number (708) 957-2100, as your correspondence is most welcome. Additionally, the physical location of the single location of Inter Med Oncology can be found at the coordinates 41.564289,-87.680983 as well as the street address 17901 Governors Highway in Homewood, Illinois 60430.
For its online presence, you may visit Inter Med Oncology’s website at alphamedphysicians.com and engage with its social media outlets through on Twitter and on Facebook.